SpectronRx raises $85 million to expand isotope production and manufacturing capacity - DOTmed

4/2/2026

OrbiMed-backed Pinnacle adds $89M series B to power oral peptide pipeline - Fierce Biotech

3/26/2026

Phase 3 China obesity biotech gets $72M, including support from OrbiMed - Endpoints News

3/2/2026

OrbiMed Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing - The Motley Fool

2/20/2026

ORBIMED ADVISORS LLC - Portfolio Stock Holdings - Quiver Quantitative

12/31/2025

Biogen licenses a possible immune drug from OrbiMed-backed biotech - biopharmadive.com

10/24/2025

AirStrip Technologies Secures $50M from OrbiMed - The SaaS News

10/10/2025

Orbimed advisors buys Adicet Bio (ACET) shares worth $5 million - Investing.com

10/10/2025

AirStrip Secures $50 Million Growth Credit Commitment and Additional Equity Investment from OrbiMed to Accelerate Innovation and Expansion - Business Wire

10/9/2025

Biovance Capital leads Series A Financing in Mondego Bio together with OrbiMed and Torrey Pines - PR Newswire

9/18/2025

OrbiMed secures $1.86B for credit and royalty fund V - MobiHealthNews

8/6/2025

OrbiMed snags $1.9 billion for fifth healthcare fund amid 'challenging' market - FirstWord Pharma

8/4/2025

Exclusive | Healthcare Investor OrbiMed Raises $1.86 Billion for Royalty and Credit Fund - WSJ

8/4/2025

OrbiMed racks up $1.86bn for fifth royalty and credit fund - venturecapitaljournal.com

8/4/2025

OrbiMed expands investment to $85 million in Swiss firm’s drill-free cavity treatment - Oral Health Group

7/17/2025